

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Stimulator of interferon genes (STING) is an intracellular signaling molecule that senses cytosolic DNA to regulate the production of type I interferons (IFNs) and other inflammatory cytokines. C-176 is a covalent STING inhibitor that effectively decreases STING-mediated IFNβ reporter activity at the dosage of 0.01 – 1.25 μM. Treatment of [3H]-palmitate labelled HEK293T cells with 1 μM C-176 inhibited STING palmitoylation. In wild-type C57BL/6J mice, pretreatment with 750 nmol C-176 for 1h and 4h resulted in a significant reduction of STING agonist-induced IFNs and IL-6 production in serum. Two-week injection of Trex1 deficient mice with C-176 (7.5 μL/day) significantly decreased serum levels of type I IFNs and suppressed cardiac inflammatory parameters. Treatment with C-176 in Trex1-/- mice for three months attenuated systemic inflammatory signs in smooth muscle, tongue and stomach[1]. |
| 作用机制 | C-176 is a nitrofuran derivative that acts as a STING inhibitor by covalently binding to the Cys91 of mouse STING[1]. |
| Concentration | Treated Time | Description | References | |
| HK-2 cells | 3 μM | 48 h | Inhibited STING signaling pathway, alleviated hypoxia-induced fibrosis and inflammatory responses | Cell Death Discov. 2024 Jul 7;10(1):314. |
| dTHP-1 cells | 1 μM | 1 h | Pretreatment with C-176 significantly decreased the mRNA expression of IFN-β and IL-1β and slightly reduced the phosphorylation of NF-κB p65. Additionally, C-176 pretreatment suppressed the cleavage of caspase-1 and GSDMD, indicating that the STING signaling pathway is not involved in noncanonical inflammasome activation during HAdV infection. | Front Immunol. 2023 Apr 18;14:1169968. |
| MPC5 mouse podocytes | 1 µM | C176 ameliorated palmitic acid (PA)-induced podocyte injury, as evidenced by restored protein levels of nephrin and podocin, reduced apoptosis, decreased phosphorylation of TBK1 and NF-κB p65, and reduced levels of IL-6 and TNF-α. | iScience. 2022 Sep 16;25(10):105145. | |
| H446 cells | 1 μM | 48 h | To detect the expression levels of STING pathway-related proteins. The results showed that the protein expression levels of p-IRF3 and p-STING decreased after treatment with C-176 | Cell Death Discov. 2023 Aug 5;9(1):289. |
| H1688 cells | 1 μM | 48 h | To detect the expression levels of STING pathway-related proteins. The results showed that the protein expression levels of p-IRF3 and p-STING decreased after treatment with C-176 | Cell Death Discov. 2023 Aug 5;9(1):289. |
| BV2 cells | 0.5 μM | 1 h | To investigate the anti-inflammatory effects and mechanisms of C-176 in an in vitro SAH model, results showed that C-176 significantly decreased the expression of M1 microglial markers and upregulated AMPK phosphorylation. | J Neuroinflammation. 2020 May 25;17(1):165. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Oxidative stress-induced retina degeneration model | Intraperitoneal injection | 10 mg/kg | Once daily for 3 days | C176 inhibited SI-induced cGAS-STING activation and reduced retina destruction and subretinal immune cell infiltration. | Cell Death Differ. 2022 Sep;29(9):1816-1833 |
| Mice | Unilateral ureteral obstruction (UUO) model | Intraperitoneal injection | 750 nM/mouse | Once daily for 14 days | Inhibited STING signaling pathway, alleviated UUO-induced renal fibrosis and inflammation | Cell Death Discov. 2024 Jul 7;10(1):314. |
| Mice | LLC lung metastasis model | Intraperitoneal injection | 13.4 mg/kg | Once daily for 24 days | STING inhibition significantly reversed the STING-activated DC maturation and migration in Tfam-/- mice and promoted tumor progression and metastasis | J Immunother Cancer. 2023 Mar;11(3):e005430 |
| Mice | Subcutaneous xenograft model | Intraperitoneal injection | 5 mg/kg | Once daily for 7 days | To evaluate the effect of C-176 on the GPR162-STING signaling pathway induced by radiotherapy, results showed that C-176 significantly reduced the anti-tumor effect of radiotherapy | Signal Transduct Target Ther. 2023 Feb 1;8(1):48 |
| Mice | CKD/ApoE−/− mice | Intraperitoneal injection | 4 mg/kg | Every other day for 12 weeks | Significantly retarded AS progression and improved plaque vulnerability | Adv Sci (Weinh). 2021 Jan 6;8(5):2002738. |
| Mice | Db/db mice | Intraperitoneal injection | 5 mg/kg | Once daily for 21 consecutive days | C176 inhibited the cGAS-STING pathway and ameliorated podocyte injury in db/db mice, as evidenced by reduced microalbuminuria, alleviated glomerular hypertrophy and mesangial expansion, restored nephrin levels, and reduced podocyte apoptosis. | iScience. 2022 Sep 16;25(10):105145. |
| C57BL/6J mice | Subarachnoid hemorrhage (SAH) model | Intraperitoneal injection | 750 nM, 200 μL | Single dose, 30 minutes post-modeling | To investigate the neuroprotective effects and mechanisms of C-176 in an SAH model, results showed that C-176 significantly attenuated brain edema, neuronal injury, and improved both short-term and persistent neurological dysfunction, with its anti-inflammatory effects partially mediated by AMPK signaling. | J Neuroinflammation. 2020 May 25;17(1):165. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01308658 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> Berlin, Germany 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.79mL 0.56mL 0.28mL |
13.96mL 2.79mL 1.40mL |
27.93mL 5.59mL 2.79mL |
|
| CAS号 | 314054-00-7 |
| 分子式 | C11H7IN2O4 |
| 分子量 | 358.09 |
| SMILES Code | O=C(C1=CC=C([N+]([O-])=O)O1)NC2=CC=C(I)C=C2 |
| MDL No. | MFCD00784208 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | JBIKQXOZLBLMKI-UHFFFAOYSA-N |
| Pubchem ID | 1103958 |
| 存储条件 |
In solvent -20°C: 1个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 60 mg/mL(167.56 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 无水乙醇: 2.5 mg/mL(6.98 mM),配合低频超声,并水浴加热至45℃助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1